GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...
QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...
Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...
The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...
Customers can make sure they are getting the right treatment for their illnesses by taking a three-in-one multiplex test at Kroger's Little Clinics that test for the flu, RSV and COVID-19 all at ...
Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer Although predictive multiplex somatic ...
After COVID-19 NPIs lifted, respiratory infections reverted toward pre pandemic seasonality, with winter peaks for RSV and Influenza A. Multiplex PCR surveillance highlighted rhinovirus dominance and ...
After the unusually mild 2020-2021 influenza (flu) season, which was caused in part by the community mitigation factors used to control the spread of COVID-19, it's evident that the seasonal spread of ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results